NCT00442559

Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)

Korean Study of "Real-World" Montelukast Use in Mild Asthmatic Children With Concomitant Allergic Rhinitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 191 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 2 Years – 14 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess real-world effectiveness of montelukast in children (2 to 14 years) with asthma and allergic rhinitis.

Conditions

• Asthma
• Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	montelukast sodium	Montelukast 4/5 mg tablet (oral chewable), once daily, 12 weeks to up to 12 months
DRUG	inhaled corticosteroid	Inhaled corticosteroid solution, 1-4 puffs daily, 12 weeks to up to 12 months

Timeline

• Start date: 2005-01-01
• Primary completion: 2007-10-01
• Completion: 2007-10-01
• First posted: 2007-03-02
• Last updated: 2024-05-13
• Results posted: 2008-11-18